Literature DB >> 16960728

[Cystitis emphysematosa--a case report].

V Geyer1, A Hegele, R Häussermann, P Olbert, R Hofmann.   

Abstract

We present a rare case of cystitis emphysematosa in an 85-year-old female patient in whom the typical risk factors were present: diabetes of long standing, neurogenic bladder and urinary infection with E.coli. Thanks to early diagnosis by cystoscopy and abdominal CT, after antibiotic treatment, appropriate insulin therapy and continuous bladder drainage the course was uneventful. The patient was fit to leave hospital after 14 days.

Entities:  

Mesh:

Year:  2007        PMID: 16960728     DOI: 10.1007/s00120-006-1182-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  5 in total

Review 1.  Emphysematous cystitis: a review of the spectrum of disease.

Authors:  H J Quint; G W Drach; W D Rappaport; C J Hoffmann
Journal:  J Urol       Date:  1992-01       Impact factor: 7.450

2.  Gas-forming infections in genitourinary tract.

Authors:  N P Patel; R W Lavengood; M Fernandes; J N Ward; M P Walzak
Journal:  Urology       Date:  1992-04       Impact factor: 2.649

3.  Emphysematous cystitis.

Authors:  C Perlemoine; D Neau; J M Ragnaud; H Gin; A Sahnoun; J L Pariente; V Rigalleau
Journal:  Diabetes Metab       Date:  2004-09       Impact factor: 6.041

Review 4.  Urinary tract infection in diabetes.

Authors:  Lindsay E Nicolle
Journal:  Curr Opin Infect Dis       Date:  2005-02       Impact factor: 4.915

5.  Emphysematous cystitis with severe hemorrhagic anemia resulting from diabetes mellitus type 2.

Authors:  Fumie Sakamoto; Hideki Taki; Toshiaki Yamagata; Sayaka Tsukurimichi; Masahiko Ikeda; Toshihiro Sugiura; Akira Wada; Yoshifumi Fukuhara; Hideki Etani; Ryohei Todo
Journal:  Intern Med       Date:  2004-04       Impact factor: 1.271

  5 in total
  1 in total

Review 1.  [Modern neurological treatment strategies for patients with spinal cord injury].

Authors:  B Domurath; J Kutzenberger
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.